October is recognised as Breast Cancer Awareness Month globally, a period dedicated to encouraging early detection and preventive screening.
As an ISO-accredited laboratory, Cerba Lancet Eswatini is committed to advancing women’s health through reliable, cutting-edge diagnostic testing designed to detect breast cancer at its earliest and most treatable stage. Cerba Lancet Eswatini, an ultramodern medical diagnostic laboratory established in 2004, has dedicated over two decades of medical excellence.
During this time, we have grown to become a medical laboratory service provider to trusted clinics, hospitals and patients.
Understanding the importance of early detection
Breast cancer remains one of the most prevalent cancers affecting women worldwide. When detected early, chances of successful treatment can increase dramatically. Regular check-ups coupled with laboratory and imaging tests form the cornerstone of early diagnosis and intervention.
Cerba Lancet Eswatini offers a comprehensive range of specialised tests to aid both clinicians and patients in the accurate diagnosis and management of breast cancer.
Our Breast Cancer Testing Services
CA 15-3 (Cancer Antigen 15-3)
This blood test measures the level of CA 15-3, a protein that can be elevated in individuals with breast cancer.
- Purpose: It helps monitor the progression or recurrence of breast cancer and assess how well treatment is working.
- Ideal for: Patients undergoing or completing breast cancer therapy, as well as follow-up care.
BRCA 1 & BRCA 2 Gene Testing
The BRCA1 and BRCA2 genes are responsible for repairing DNA damage in cells. Mutations in these genes significantly increase the risk of developing breast and ovarian cancers.
- Purpose: This genetic test identifies inherited mutations, helping individuals understand their genetic predisposition to breast cancer.
- Ideal for: Individuals with a family history of breast, ovarian or related cancers who wish to take proactive steps towards prevention and early monitoring.
Fine Needle Aspiration (FNA) Cytology
FNA is a minimally invasive procedure used to extract a small sample of cells from a suspicious breast lump.
- Purpose: To determine whether a lump is benign (non-cancerous) or malignant (cancerous).
- Ideal for: Patients with palpable breast lumps or abnormal imaging findings who require further evaluation.
Breast biopsy testing
A breast biopsy involves the removal of a small tissue sample from the breast for detailed laboratory analysis.
- Purpose: To provide a definitive diagnosis of breast cancer and determine the type and stage of the disease.
- Ideal for: Patients whose imaging or FNA results suggest the possibility of cancer.
At Cerba Lancet Eswatini, we understand that time is critical when it comes to diagnosis, in the fight against breast cancer.
Our advanced laboratory equipment, experienced pathologists and stringent quality assurance systems ensure precision, reliability and fast turnaround times.
We work hand-in-hand with doctors, oncologists and imaging specialists to provide a holistic approach to breast health from screening to diagnosis and ongoing monitoring.
Leave a comment